Tacedinaline and its Impurities

Tacedinaline, also known as Acetyldinaline, has been in phase III clinical trials by Pfizer for the treatment of advanced non-small cell lung cancer. Reference standards of Tacedinaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.